India to Australia: Mycophenolate Export Trade Route

The India to Australia Mycophenolate corridor is one of India's established pharmaceutical export routes, with 127 shipments documented worth a combined $20.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $161.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with mycophenolate's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 17.7%, placing it at rank #4 among India's top mycophenolate export destinations globally.

On the import side, key buyers of Indian mycophenolate in Australia include APOTEX PTY LTD, PHARMACOR PTY LTD, PHARMACOR PTY LTD.,. and 24 others. APOTEX PTY LTD is the single largest importer with 9 shipments valued at $12.6M USD.

India's mycophenolate exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, ALKEM LABORATORIES LIMITED, SANDOZ PRIVATE LIMITED — together account for 90% of total trade value on this route. The average shipment value of $161.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as mycophenolate sdz 500mg 50fct au materia and pharmaceutical products : pharmacor mycophenolate 500mg(5x10's)aus, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX PTY LTD is the largest importer with 9 shipments worth $12.6M USD — representing 62% of all mycophenolate imports from India on this route. A total of 27 buyers are active on this corridor.